Technology Prolactin Receptor Antibodies For Targeted Cancer Therapy And Diagnosis Novel antibodies precisely targeting cancer cells by binding to the Prolactin Receptor (PRLR) to diagnose cancer, direct immune cells to destroy tumors, and inhibit cancer growth signals, without affecting healthy…
Technology Antibody-Based Cell Expansion Technology For Large-Scale And Safe Amplification Of Gamma Delta T Cells Novel antibodies to rapidly and safely expand γδ T cells enabling large-scale production for cancer immunotherapies like γδ CAR-T cells, and potentially boosting these cells directly in patients The…
News AMOpportunities Becomes the Fifth Venture Investment Through the UChicago Startup Investment Program A University program dedicated to investing in startups that are raising Series A funding.
News Meet Polsky Member of the Month: Jill Kahane Jill Kahane joined as a member of the Polsky Center for Entrepreneurship and Innovation’s Polsky Exchange in March 2018. She was first introduced to the Polsky Center through a lunch...
News Halo Awards to Honor ‘Heroes Of Medicine’ and 40 Under 40 Chicago Scientists, Featuring Many Polsky Partners The second Annual Halo Awards will take place Saturday, October 12, at 6:00 p.m. at the Museum of Science and Industry, celebrating the city’s “Heroes of Medicine” and the 40...
News Halo Awards Honor ‘Heroes Of Medicine’ and 40 Under 40 Chicago Scientists Many UChicago and Polsky-affiliated scientists and researchers were among the honorees.
News Absolute Antibody Partners with the Recombinant Antibody Network to Facilitate Access to Engineered Recombinant Antibodies Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, has announced a partnership with the Recombinant Antibody Network (RAN), a consortium of three expert centers at the...
News Patent of the Week: Improving the Performance of Antibody Fragments Antibody fragments, including Fabs, which bind to immune response-triggering substances, or antigens, have demonstrated utility in various research and diagnostic applications. However, their structure limits their use, so researchers have engineered...
News Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies The Recombinant Antibody Network (RAN), a consortium comprising research groups from UC San Francisco (UCSF), the University of Chicago, and the University of Toronto have expanded a previous research collaboration...
Program UChicago Private Markets Program Explore careers in private markets through workshops, theory, case studies, and networking opportunities.
News Polsky Center and the College’s Office of Career Advancement Launch New Program to Prepare Students for Careers in Private Markets The University of Chicago Booth School of Business and the College’s Office of Career Advancement recently hosted its first Private Markets Program, which was made possible due to a generous...
News From Discovery to Dissemination: How a New Collaboration is Helping Get Knowledge ‘Out the Door’ Healthcare investment firm Deerfield Management recently visited the University of Chicago to meet with researchers and discuss Hyde Park Discovery, a new collaboration to advance discoveries from the lab. “I’m...
